First Header Logo Second Header Logo

Connection

Samuel Lentz to Oligopeptides

Back to Details
This is a "connection" page, showing publications Samuel Lentz has written about Oligopeptides.
Samuel Lentz
Connection Strength
0.054
Oligopeptides
  1. Hoffman MA, Blessing JA, Lentz SS. A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2003 Apr; 89(1):95-8.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.